LAWRENCE, Mass., Aug. 11,
2017 /PRNewswire/ -- NxStage Medical, Inc.
(Nasdaq: NXTM), a leading medical technology company focused
on advancing renal care, today announced that its NxStage Kidney
Care subsidiary is partnering with Dialyze Direct, a leader in the
area of geriatric dialysis and an innovative provider of
staff-assisted home hemodialysis to patients in SNFs, to better
support the needs of Ohio's
skilled nursing facility (SNF) population with end stage renal
disease (ESRD). Dialyze Direct will be implementing its unique
model of care specifically designed for geriatric SNF patients to
provide on-site dialysis using the NxStage System One.
On-site dialysis performed at a SNF removes organizational and
operational challenges for dialysis centers and care facilities,
while reducing or eliminating the stress placed on patients during
transportation. The portability of the NxStage System One
makes it possible to provide SNF patients with access to on-site
dialysis, including more frequent hemodialysis, versus transporting
them, often by ambulance, to an off-site dialysis center three
times per week. Studies of SNF patients performing on-site more
frequent hemodialysis have shown reductions in both mortality and
hospitalizations.1-3 In addition, by performing dialysis
treatments on-site, patients have greater flexibility and are able
to attend scheduled meals, rehabilitation therapy, and social
activities.
"Our mission is to deliver innovative and compassionate dialysis
care to geriatric patients in skilled nursing facilities and we
realized we needed an alternative strategy to meet the growing
demand for our services in certain states such as Ohio where we do not yet have an operating
presence," said Henry Kauftheil,
Chairman of Dialyze Direct. "NxStage is an ideal partner to help us
expand our footprint and bring our much-needed services to SNF
patients."
"We believe the SNF market represents an opportunity to improve
outcomes and quality of life for skilled nursing patients, as well
as to improve overall costs of care, by reducing transportation
costs and re-hospitalization rates," said Jeff Burbank, CEO and Founder of NxStage
Medical. "We look forward to working with Dialyze Direct to address
unmet needs in SNF ESRD patient care."
Service providers, skilled nursing administrators or others
interested in learning more about on-site dialysis with the System
One at skilled nursing facilities can
visit www.nxstage.com/snf for more information.
The NxStage System One is a prescription device and, like all
medical devices, involves some risks. The risks associated with
hemodialysis treatments in any environment include, but are not
limited to, high blood pressure, fluid overload, low blood
pressure, heart-related issues, and vascular access complications.
The medical devices used in hemodialysis therapies may add
additional risks including air entering the bloodstream, and blood
loss due to clotting or accidental disconnection of the blood
tubing set. Patients should consult with their doctor to understand
the risks and responsibilities of home and/or more frequent
hemodialysis using the NxStage System One. Additionally, the
reported benefits of home and/ or more frequent hemodialysis may
not be experienced by all patients. Patients and providers are
encouraged to contact their state regulators to discuss
state-specific regulations that may impact dialysis in the skilled
nursing facility setting.
About the NxStage System One
The NxStage System One is
the first and only truly portable hemodialysis system cleared
specifically by the FDA for home hemodialysis and home
nocturnal hemodialysis. The simplicity and revolutionary size (just
over a foot tall) are intended to allow convenient use in patients'
homes and give patients the freedom to travel with their therapy.
When combined with the NxStage PureFlow™ SL Dialysis Preparation
System, patients are able to further simplify, using ordinary tap
water to create dialysis fluid on-site on-demand. Unlike
conventional hemodialysis systems, the System One family of
products requires no special infrastructure to operate. Under the
guidance of their physician, patients can use the NxStage System
One, with their trained partners, where, how and when it best meets
their needs, including while they are sleeping - at home or on
vacation and at a medically appropriate treatment frequency. In
addition, NxStage's Nx2me Connected Health® platform collects
important NxStage System One and patient information for flexible
viewing, monitoring and reporting that may improve patient
management and patient retention, as well as simplify alternative
site care. The System One is also used to provide a range of
flexible therapy options in more traditional care settings such as
hospitals, dialysis centers and skilled nursing facilities. Its
safety and performance have been demonstrated by experience with
more than 14 million treatments with over 30 thousand patients
around the world. www.nxstage.com.
About Dialyze Direct, LLC
Dialyze Direct LLC provides
innovative and compassionate staff-assisted home hemodialysis
services to the geriatric patients residing in skilled nursing
facilities (SNFs). Dialyze Direct's core mission is to improve the
dignity and quality of life of geriatric patients with End-Stage
Renal Disease (ESRD), while significantly reducing the overall
costs of these patients to the healthcare system. Dialyze Direct
delivers dialysis care with a gentler form of treatment built
around more frequent dialysis sessions using the NxStage System One
with modified treatment protocols. Dialyze Direct created a
unique model of care combining direct oversight with enhanced and
proprietary protocols and procedures specifically designed for
geriatric ESRD patients in SNFs, through which Dialyze Direct has
been able to achieve significantly improved outcomes in this
population segment while reducing overall payor costs by
eliminating transportation and minimizing re-hospitalizations. The
Dialyze Direct model is also breaking new ground in aiming to
reduce the disruption the geriatric ESRD patient demographic makes
on SNF operations. Dialyze Direct currently provides services in
Florida, Texas, New
York, New Jersey,
Ohio, and Pennsylvania.
About NxStage Kidney Care
NxStage Kidney Care, Inc.,
a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), is innovating
a dialysis care model that is intended to support and encourage
patient-centered care and provide enhanced access to the
life-changing benefits of home therapy as well as flexible
in-center options. By leveraging NxStage's home leadership and the
innovative technology of its System One, NxStage Kidney Care is
committed to helping patients take control of their dialysis and to
allowing physicians the flexibility to prescribe what is truly best
for their patients. For more information, please visit
www.nxstagekidneycare.com or call (866) 694-2707.
About NxStage Medical
NxStage Medical, Inc.
(Nasdaq: NXTM) is a leading medical technology company,
headquartered in Lawrence, Massachusetts, USA, that develops,
manufactures and markets innovative products for the treatment of
ESRD and acute kidney failure. NxStage also has established a small
number of dialysis clinics committed to the development of
innovative care delivery models for patients with ESRD. For more
information on NxStage and its products and services, please visit
the Company's websites at www.nxstage.com and
www.nxstagekidneycare.com.
Forward-Looking Statements
This release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements contained
in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended
to identify forward-looking statements. Actual results may differ
materially from those indicated by these forward-looking statements
as a result of various important factors including those that are
discussed in NxStage's filings with the Securities and Exchange
Commission, including its Quarterly Report on Form 10-Q for the
quarter ended June 30, 2017. NxStage
is under no obligation to (and expressly disclaims any such
obligation to) update or alter its forward-looking statements,
whether as a result of new information, future events or
otherwise.
Media contact:
Kristen K. Sheppard, Esq.
ksheppard@nxstage.com
References:
1. Weinhandl ED, Lie J, Gilbertson DT,
Arneson TJ, Collins AJ. Survival in daily home hemodialysis and
matched thrice-weekly in-center hemodialysis patients. J Am Soc
Nephrol. 2012;23(5):895-904.
2. Yang A, Lee WY, Hocking K, Xelay Acumen, Inc., Affiliated
Dialysis. Survival comparison of daily home hemodialysis vs
conventional dialysis in the nursing home setting. Nephrol News
Issues. 2015;29(2):25-27, 30-31.
3. Bednar B. Improving Kidney Care for Residents in Nursing
Facilities: A National Model. Nephrol News Issues.
2016:30-34.
View original content with
multimedia:http://www.prnewswire.com/news-releases/nxstage-kidney-care-and-dialyze-direct-to-provide-on-site-dialysis-to-skilled-nursing-facility-patients-in-ohio-300503236.html
SOURCE NxStage Medical, Inc.